Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Terminated(1)

Detailed Status

Completed2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

withdrawn133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
withdrawnnot_applicable

ROTEM and Dietary Supplements

NCT03125551
completednot_applicable

Effect of Garlic Tablet Some Indicators Related to Atherosclerosis

NCT01948453
completednot_applicable

Docetaxel Plus Garlic in Treating Patients With Locally Advanced or Metastatic Breast Cancer

NCT00079170

Clinical Trials (3)

Showing 3 of 3 trials
NCT03125551Not Applicable

ROTEM and Dietary Supplements

Withdrawn
NCT01948453Not Applicable

Effect of Garlic Tablet Some Indicators Related to Atherosclerosis

Completed
NCT00079170Not Applicable

Docetaxel Plus Garlic in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Completed

All 3 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
3